Global implementation of the world health organization's International Classification of Diseases (ICD)-11: The allergic and hypersensitivity conditions model.
International Classification of Diseases
World Health Organization
allergy
classification
definition
hypersensitivity
implementation
terminology
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
16
05
2020
revised:
03
06
2020
accepted:
08
06
2020
pubmed:
25
6
2020
medline:
15
5
2021
entrez:
25
6
2020
Statut:
ppublish
Résumé
The International Classification of Diseases (ICD) provides a common language for use worldwide as a diagnostic and classification tool for epidemiology, clinical purposes and health management. Since its first edition, the ICD has maintained a framework distributing conditions according to topography, with the result that some complex conditions, such as allergies and hypersensitivity disorders (A/H) including anaphylaxis, have been poorly represented. The change in hierarchy in ICD-11 permitted the construction of the pioneer section addressed to A/H, which may result in more accurate mortality and morbidity statistics, including more accurate accounting for mortality due to anaphylaxis, strengthen classification, terminology and definitions. The ICD-11 was presented and adopted by the 72nd World Health Assembly in May 2019, and the implementation is ongoing worldwide. We here present the outcomes from an online survey undertaken to reach out the allergy community worldwide in order to peer review the terminology, classification and definitions of A/H introduced into ICD-11 and to support their global implementation. Data are presented here for 406 respondents from 74 countries. All of the subsections of the new A/H section of the ICD-11 had been considered with good accuracy by the majority of respondents. We believe that, in addition to help during the implementation phase, all the comments provided will help to improve the A/H classification and to increase awareness by different disciplines of what actions are needed to ensure more accurate epidemiological data and better clinical management of A/H patients.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2206-2218Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Références
Cornet R, Chute CG. Health concept and knowledge management: twenty-five year of evolution. Yearb Med Inform. 2016;2(Suppl 1):S32-S41.
Demoly P, Tanno LK, Akdis CA, et al. Global classification and coding of hypersensitivity diseases - an EAACI - WAO survey, strategic paper and review. Allergy. 2014;69:559-570.
World Health Organization ICD-11. website cited, available: https://www.who.int/classifications/icd/en/. Accessed February 2020.
Knibbs GH. The International classification of disease and causes of death and its revision. Med J Aust 1929;1:2-12. Available: https://www.who.int/classifications/icd/en/HistoryOfICD.pdf. Accessed June 29, 2020.
Moriyama IM, Loy RM, Robb-Smith AHT. In Rosenberg HM, Hoyert DL, eds. History of the statistical classification of diseases and causes of death. Hyattsville, MD: National Center for Health Statistics; 2011.
National Academy on an Aging Society. Chronic Conditions: A challenge for the 21st Century. 2000.
Centers for Disease Control. “CDC Fast Facts A-Z”, Vital Health Statistics. 2003 [cited 28 Oct 2011]. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2018_SHS_Table_A-2.pdf. Accessed September 5, 2011
Center of Disease Control and Prevention (CDC) website. cited, available: https://www.cdc.gov/nchs/fastats/health-expenditures.htm. Accessed February, 2020.
Tanno LK, Calderon MA, Goldberg BJ, Akdis CA, Papadopoulos NG, Demoly P. Categorization of allergic disorders in the New World Health Organization International Classification of diseases. Clin Transl Allergy. 2014;4:42.
Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy. 2012;67:783-789.
Papadopoulos NG, Agache I, Bavbek S, et al. Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy. 2012;2:21.
Pawankar R, Canonica GW, Holgate ST, Lockey RF, Blaiss M. The WAO White Book on Allergy (Update. 2013) cited, available: https://www.worldallergy.org/wao-white-book-on-allergy. Accessed June, 2020.
Tanno LK, Calderon MA, Smith HE, et al. Dissemination of definitions and concepts of allergic and hypersensitivity conditions. World Allergy Organ J. 2016;9:24.
World Health Organization. ICD-11 Beta Draft website. Cited, http://apps.who.int/classifications/icd11/browse/l-m/en Accessed January, 2020.
Tanno LK, Casale T, Papadopoulos NG, et al. A call to arms of specialty societies to review the WHO International Classification of Diseases, Eleventh Revision terms appropriate for the diseases they manage: the example of the Joint Allergy Academies. Allergy Asthma Proc. 2017;38(4):54-55.
Tanno LK, Calderon MA, Goldberg BJ, et al. Constructing a classification of hypersensitivity/allergic diseases for ICD-11 by sourcing the allergist community. Allergy. 2015;70:609-615.
Tanno LK, Calderon MA, Demoly P, on behalf the Joint Allergy Academies. New allergic and hypersensitivity conditions section in the international classification of diseases-11. Allergy Asthma Immunol Res. 2016;8:383-388.
Tanno LK, Simons FER, Annesi-Maesano I, Calderon MA, Aymé S, Demoly P. Joint Allergy Academies. Fatal anaphylaxis registries data support changes in the who anaphylaxis mortality coding rules. Orphanet J Rare Dis. 2017;12:8.
Tanno LK, Bierrenbach AL, Simons FER, et al. Critical view of anaphylaxis epidemiology: open questions and new perspectives. Allergy Asthma. Clin Immunol. 2018;14:12.
Tanno LK, Calderon M, Papadopoulos NG, Demoly P. Mapping hypersensitivity/allergic diseases in the International Classification of Diseases (ICD)-11: cross-linking terms and unmet needs. Clin Transl Allergy. 2015;5:20.
Tanno LK, Calderon MA, Demoly P, on behalf the Joint Allergy Academies. Making allergic and hypersensitivity conditions visible in the International Classification of Diseases-11. Asian Pac Allergy. 2015;5:193-196.
Tanno LK, Calderon MA, Demoly P, on behalf the Joint Allergy Academies. Optimization and simplification of the allergic and hypersensitivity conditions classification for the ICD-11. Allergy. 2016;71:671-676.
Tanno LK, Calderon MA, Papadopoulos NG, et al. Revisiting desensitization and allergen immunotherapy concepts for the International Classification of Diseases (ICD)-11. J Allergy Clin Immunol Pract. 2016;4:643-649.
Tanno LK, Calderon MA, Li J, Casale T, Demoly P. Updating Allergy/Hypersensitivity diagnostic procedures in the WHO ICD-11 revision. J Allergy Clin Immunol Pract. 2016;4:650-657.
Tanno LK, Calderon MA, Papadopoulos NG, et al. Surveying the new allergic and hypersensitivity conditions chapter of the International classification of diseases (ICD)-11. Allergy. 2016;71:1235-1240.
Tanno LK, Calderon M, Demoly P, Joint Allergy Academies. Supporting the validation of the new allergic and hypersensitivity conditions section of the World Health Organization International Classification of Diseases-11. Asia Pac Allergy. 2016;6:149-156.
Tanno LK, Calderon M, Sublett JL, Casale T, Demoly P, Joint Allergy Academies. Smoothing the transition from international classification of diseases, tenth revision, clinical modification to international classification of diseases, eleventh revision. J Allergy Clin Immunol Pract. 2016;4:1265-1267.
Tanno LK, Bierrenbach AL, Calderon MA, Sheikh A, Simons FER, Demoly P. Joint Allergy Academies. Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)-11 revision. Allergy. 2017;72:120-125.
Tanno LK, Ansotegui I, Demoly P. Globalization and anaphylaxis. Curr Opin Allergy Clin Immunol. 2018;18(5):365-369.
Tanno LK, Molinari N, Bruel S, et al. Field-testing the New Anaphylaxis' classification for the WHO International Classification of Diseases (ICD)-11 revision. Allergy. 2017;72(5):820-826.
Tanno LK, Sublett JL, Meadows JA, et al. Perspectives of the International Classification of Diseases (ICD)-11 in allergy clinical practice in the United States of America. Ann Allergy Asthma Immunol. 2017;118(2):127-132.
Tanno LK, Chalmers RJG, Calderon MA, Aymé S, Demoly P, on behalf the Joint Allergy Academies. Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization's (WHO) International Classification of Diseases (ICD-11). Orphanet J Rare Dis. 2017;12(1):53.
Tanno LK, Calderon MA, Linzer JF, Chalmers RJG, Demoly P, on behalf of the Joint Allergy Academies. Collaboration between specialties for respiratory allergies in the international classification of diseases (ICD)-11. Respiratory Res. 2017;18(1):34.
Tanno LK, Haahtela T, Calderon MA, Cruz A, Demoly P, Joint Allergy Academies. Implementation gaps for asthma prevention and control. Respir Med. 2017;130:13-19.
Tanno LK, Torres MJ, Castells M, Demoly P, Joint Allergy Academies. What can we learn in drug allergy management from World Health Organization's International classifications? Allergy. 2018;73(5):987-992.
Tanno LK, Demoly P. Lessons of drug allergy management through the World Health Organization’s International Classification of Diseases (ICD)-11. Curr Treatment Opin in Allergy. 2018;5(1):52-59.
Tanno LK, Demoly P, on behalf of the Joint Allergy Academies. How can the World Health Organization's International Classification of Diseases (ICD)-11 change the clinical management of anaphylaxis? Expert Rev Clin Immunol. 2018;14(10):783-786.
Tanno LK, Demoly P, Joint Allergy Academies. Are outcome measures in allergic diseases relevant for the WHO's International Classification of Diseases in allergology? Curr Opin Allergy Clin Immunol. 2019;19(3):198-203.
Tanno LK, Chalmers R, Bierrenbach AL, et al. Changing the history of anaphylaxis mortality statistics through the World Health Organization’s International Classification of Diseases (ICD)-11. J Allergy Clin Immunol. 2019;144(3):627-633.
Lancet T. ICD-11. Lancet 2019;393(10188):2275.
World Health Organization. Collaborating Centres list website. http://apps.who.int/whocc/Detail.aspx?cc_ref=FRA-133&designation_date1=1/6/2018&designation_date2=18/7/2018& Accessed December, 2019.
World Health Organization. MSAC website. https://www.who.int/classifications/icd/revision/en/. Accessed December, 2019.
Johansson S, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Imunnol. 2004;113:832-836.
The European Academy of Allergy and Clinical Immunology (EAACI). A European Declaration on Allergen Immunotherapy. http://www.eaaci.org/attachments/1637_1307947625_European%20Declaration%20on%20Allergen%20Immunotherapy2011.pdf. Accessed June, 2020.
Demoly P, Adkinson NF, Brockow K, et al. International Consensus on drug allergy. Allergy. 2014;69:420-437.
Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol. 2006;117:391-397.
Scadding G, Hellings P, Alobid I, et al. Diagnostic tools in Rhinology EAACI position paper. Clin Transl Allergy. 2011;1(1):2.
Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl. 2007;20:1-136.
Bousquet J, Schünemann HJ, Zuberbier T, et al. Development and implementation of guide- lines in allergic rhinitis - an ARIA-GA2LEN paper. Allergy. 2010;65:1212-1221.
Bacharier LB, Boner A, Carlsen K-H, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy. 2008;63:5-34.
Asthma. Quick asthma facts & The Faces of asthma [Internet]. Geneva: World Health Organization; 2010. http://www.who.int/respiratory/asthma/en/.
Masoli M, Fabian D, Holt S, Richard Beasley for the Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA. Dissemination Committee Report. Allergy. 2004;59:469-478.
Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The correlation between asthma control and health status: the GOAL study. Eur Respir J. 2007;29:56-62.
Papadopoulos NG, Arakawa H, Carlsen K-H, et al. International consensus on (icon) pediatric asthma. Allergy. 2012;67:976-997.
Burks AW, Tang M, Sicherer S, et al. International consensus on (ICON) Food Allergy. J Allergy Clin Immunol. 2012;129:906-920.
Simons FER, Ardusso LRF, Bilò MB, et al. International consensus on (ICON) Anaphylaxis. World Allergy Organ J. 2014;30(7):9.
Moscato G, Pala G, Cullinan P, et al. Position Paper on assessment of cough in the workplace. Allergy. 2014;69:292-304.
Leonardi A, Bogacka E, Fauquert JL, et al. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy. 2012;67:1327-1337.
La Rosa M, Lionetti E, Reibaldi M, et al. Allergic conjunctivitis: a comprehensive review of the literature. Italian J Pediatrics. 2013;39:18.
Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye. 2004;18:345-351.
Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy. Asthma and Immunology/PRACTALL Consensus Report. Allergy. 2006;61:969-987.
Bonitsis NG, Tatsioni A, Bassioukas K, Ioannidis JP. Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis. Contact Dermatitis. 2011;64:245-257.
Tan CH, Rasool S, Johnston GA. Contact dermatitis: allergic and irritant. Clin Dermatol. 2014;32:116-124.
Cicardi M, Bork K, Caballero T, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy. 2012;67:147-157.
Craig T, Pürsün EA, Bork K, et al. WAO Guideline for the Management of Hereditary Angioedema. WAO J. 2012;5:182-199.
Soares-Weiser K, Panesar SS, Rader T, et al. The diagnosis of food allergy: protocol for a systematic review. Clin Transl Allergy. 2013;3:18.
Bircher A, Scherer K. Delayed cutaneous manifestations of drug hypersensitivity. Med Clin North Am. 2010;94:711-725.
Pirmohamed M, Friedmann PS, Molokhia M, et al. Phenotype standardization for immune-mediated drug-induced skin injury. Clin Pharmacol Ther. 2011;89:896-901.
Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology. 2005;15(209):123-129.
Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN, EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy. 2005;60:1339-1349.
Bonifazi F, Jutel M, Biló BM, Birnbaum J, Muller U, EAACI Interest Group on Insect Venom Hypersensitivity. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy. 2005;60:1459-1470.
Turner PJ, Worm M, Ansotegui IJ, et al. Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organ J. 2019;12(10):100066.
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018;73(7):1393-1414.